Zobrazeno 11 - 20
of 90
pro vyhledávání: '"Yoshiaki Rai"'
Autor:
Hirofumi Mukai, Yasuaki Muramatsu, Norikazu Masuda, Yoshiko Umeyama, Masakuzu Toi, Kenichi Inoue, Hiroji Iwata, Satoshi Hashigaki, Yuko Mori, Shinji Ohno, Yoshiaki Rai
Publikováno v:
Breast Cancer (Tokyo, Japan)
BackgroundThe cyclin-dependent kinase 4/6 (CDK4/6) inhibitor palbociclib, in combination with endocrine therapy (ET), significantly prolonged progression-free survival in women with hormone receptor–positive, human epidermal growth factor receptor
Autor:
Reiko Mitsueda, Anri Gen, Yoshitaka Fujiki, Naomi Gondo, Mutsumi Sato, Junko Kawano, Koichi Kuninaka, Shuichi Kanemitsu, Megumi Teraoka, Yoshito Matsuyama, Shinichi Baba, Sugako Nomoto, Robert Sloan, Yoshiaki Rai, Yoshiaki Sagara, Yasuaki Sagara
Publikováno v:
Annals of Surgical Oncology. 29:3838-3838
Autor:
Norikazu, Masuda, Kenichi, Inoue, Rikiya, Nakamura, Yoshiaki, Rai, Hirofumi, Mukai, Shinji, Ohno, Fumikata, Hara, Yuko, Mori, Satoshi, Hashigaki, Yasuaki, Muramatsu, Takashi, Nagasawa, Yoshiko, Umeyama, Xin, Huang, Hiroji, Iwata
Publikováno v:
International Journal of Clinical Oncology
Background In the double-blind, phase 3 PALOMA-3 study, palbociclib–fulvestrant significantly prolonged progression-free survival versus placebo–fulvestrant in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor
Autor:
Kentaro Tamaki, Keely May McNamara, Yasuyo Ohi, Saki Nakagawa, Yoshiaki Rai, Minoru Miyashita, Hironobu Sasano, Katsuhiko Ono, Yasuaki Sagara, Takanori Ishida, Hisashi Hirakawa, Noriaki Ohuchi, Fouzia Guestini
Publikováno v:
Breast Cancer Research and Treatment. 173:275-288
Triple-negative breast cancer (TNBC) patients with residual disease following neoadjuvant chemotherapy (NAC) harbor higher risk of relapse, and eventual demise compared to those who achieve pathologic complete response. Therefore, in this study, we a
Autor:
Stefano Iacobelli, Malgorzata Foszczynska-Kloda, Soo-Chin Lee, Richard A. Michaelson, Juan Lacava, Raymond Smith, Vichien Srimuninnimit, Mauricio Kotliar, William Audeh, Damir Vrbanec, Young-Hyuck Im, Paola Edith Price, Maria Del Pilar, Barbara Bower, Tadeusz Pienkowski, Jedzada Maneecahvakajorn, Seppo Pyrhoenen, Alexander Marmé, Saverio Cinieri, Vladimir Semiglazov, Luciano Latini, Luis Miguel, Thitiya Sirisinha, Mario Matwiejuk, Jose Luiz Pedrini, John Allan Ellerton, Maik Hauschild, Xiaojia Wang, Christoph Maintz, Joohyuk Sohn, Estefania Monturus, Kenjiro Aogi, Eugeny Gotovkin, Ron Blachy, Douglas Otero Reye, Rita Blanchard, Bahriye Aktas, Adam Knott, Norberto Batista Lopez, L Roman, Reiki Nishimura, Piotr Tomczak, Duncan Wheatley, Emilio Alba Conejo, Yoshinori Itoh, Giraldo Kato, Petar Stefanovski, Rosa Jochim, Christoph Thomssen, Brigitte Van Eyll, Yutaka Tokuda, S O'Reilly, Paulette Blanchet, Ion Boiangiu, Nikola Vasev, Sherko Kümmel, Julie Taguchi, Do Youn Oh, David Miles, Jurandyr Andrade, Nora Giacomi, Volkmar Mueller, Eduardo Côrtes, Paula Klein, Eleonora Restuccia, Xuenong Ouyang, Leanne Budde, Andre Kallab, Elżbieta Starosławska, Takayuki Ueno, Taral Patel, Jun Horiguchi, Gilson Delgado, Sue Prill, Carol Peterson, Lourdes Calvo, Andreas Kirsch, Gustavo Ismael, Liwei Wang, Veena Charu, Dino Amadori, Pirkko Kellokumpu-Lehtinen, Brooke R. Daniel, Frank Senecal, Sanjay Yadav, Vera Gorbunova, Mikhail Kopp, Patrapim Sunpaweravong, Hiroji Iwata, Frank Priou, Kazuhiko Nakagami, Alejandra Perez, Michael R. Clemens, Marcus Schmidt, Denise A. Yardley, Birgitta Wesenberg, Priscilla Caguioa, Haruki Ogata, An Nguyen, Sung Bae Kim, Tsz-Kok Yau, Vladimir Merculov, Mikhail Lichinitser, Valorie Chan, Yoshiaki Rai, Neville Davidson, Walter E. Aulitzky, Gloria Martinez, Koji Takeda, Sherene Loi, Junichiro Watanabe, Louis Fehrenbacher, Gunta Purkalne, Shaker R. Dakhil, Claudia Schumacher, Rizvana Ahmad, Winnie Yeo, Christine Brezden-Masley, Alison Jones, Seock-Ah Im, Zetina Toache, Jeffrey Hargis, Celia Tosello, Tania Soria, Catia Angiolini, Maria De Fatima Gaui, Ravi Patel, Christopher Lobo, Andreas Schneeweiss, Priyanka Sharma, Cesar Estuardo, Randall Thomas, Adam Brufsky, Virote Sriuranpong, Zhenzhou Shen, Sandra Franco, Clive Mulatero, Wojciech Polkowski, Maria Alejandra Bartoli, Shigehira Saji, Patrick J. Flynn, Kimberly L. Blackwell, Gladys Rodriguez, Robert Robles, Timothy J. O'Rourke, Fabio Franke, Gabriel Tellez-Trevilla, Robert R. Carroll, Laura Biganzoli, Cheng Ying, Peter A. Kaufman, Mark Karwal, Mirta Varela, Darcy Spicer, Jonathan Polikoff, Roberto Hegg, Jungsil Ro, Pedro Sánchez-Rovira, Takahiro Nakayama, Edda Simoncini, María Bianconi, Liljana Kostovska-Maneva, Hugo Castro, Elza Grincuka, Jeff Neidhart, Anne Robinson, Nathan B. Green, Robert Hermann, Laura Assersohn, Teresa Gamucci, Dennis Tudtud, Nobuaki Sato, Antonio Gonzalez Martin, Victor Hugo Alencar, Jess Armor, Bruno Coudert, Nuria Ribelles, Eva Ciruelos, Daniel Cubero, Iveta Kudaba, Eduardo Cronemberger, Norikazu Masuda, Norio Kohno, Sergio J Azevedo, Vadim Shirinkin, Miguel Gil I Gil, Serafin Morales, Hirofumi Fujii, Chris Gallagher, Hernandez Monroy, Katsumasa Kuroi, Rodrigo Moura, Richy Agajanian, Zeljko Soldic, Jean-Marc Ferrero, Kenichi Inoue, Mark C. Benyunes, Davi Jendiroba, Filippo Montemurro, Masahiro Kashiwaba, Robert Quackenbush, Koichiro Tsugawa, Paulo M. Hoff, Eva-Maria Grischke, Susana De La Cruz, Vincent Hansen, Marianna Bitina, Carolyn B. Hendricks, Javier Cortes, Zee Wan Wong, Igor Kiselev, David Waterhouse, Javier Hornedo Muguiro, Mario Campone, Marianne Just, Emma Clark, Rodrigo Pereira, Sandra M Swain, Ruemu E. Birhiray, Helio Pinczowski, Wichit Arpornwirat
Publikováno v:
The Lancet. Oncology. 21(4)
Summary Background CLEOPATRA was a phase 3 study comparing the efficacy and safety of pertuzumab, trastuzumab, and docetaxel with placebo, trastuzumab, and docetaxel in patients with HER2-positive metastatic breast cancer. In the primary analysis and
Autor:
Keely May McNamara, Minoru Miyashita, Yasuaki Sagara, Hironobu Sasano, Noriaki Ohuchi, Yasuhiro Miki, Minako Sakurai, Kyoko Kikuchi, Fumiya Omata, Yasuyo Ohi, Ju Yeon Moon, Takanori Ishida, Yoshiaki Onodera, Man Ho Choi, Yoshiaki Rai
Publikováno v:
Breast Cancer Research and Treatment. 166:709-723
The tumor microenvironment plays pivotal roles in promotion of many malignancies. Cancer-associated fibroblasts (CAFs) have been well-known to promote proliferation, angiogenesis, and metastasis but mechanistic understanding of tumor–stroma interac
Autor:
R. Nakamura, Hiroji Iwata, Yoshiaki Rai, Young-Hyuck Im, Jungsil Ro, Kenichi Inoue, Cynthia Huang Bartlett, Norikazu Masuda, Patrick Schnell, Shrividya Iyer, Ke Zhang, Carla Giorgetti, Justin Hoffman, Jee Hyun Kim, Seock-Ah Im
Publikováno v:
Journal of Global Oncology, Vol 3, Iss 4, Pp 289-303 (2017)
Journal of Global Oncology
Journal of Global Oncology
Purpose To assess efficacy and safety of palbociclib plus fulvestrant in Asians with endocrine therapy–resistant metastatic breast cancer. Patients and Methods The Palbociclib Ongoing Trials in the Management of Breast Cancer 3 (PALOMA-3) trial, a
Autor:
Junko Furukawa, Koji Ohnuki, Yoshiaki Rai, Ichiro Tsuji, Kanako Ban, Yoko Murata, Takako Morita, Takashi Yamakawa, Masayuki Yoshida, Yoshio Kasahara, Yukio Koibuchi, Hideji Masuoka
Publikováno v:
Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 26:48-57
Autor:
Masahiro Kashiwaba, Hiroyoshi Doihara, Yoshiaki Rai, Kazumitsu Kanatani, Shintaro Takao, Yoshinori Ito, Shigemitsu Takashima, Norikazu Masuda
Publikováno v:
Japanese Journal of Clinical Oncology. 46:407-414
Objective Trastuzumab emtansine significantly improved progression-free survival and overall survival when compared with lapatinib-capecitabine in pretreated human epidermal growth factor receptor 2-positive advanced breast cancer. However, data in J
Autor:
Hideji Masuoka, Yoko Murata, Masayuki Yoshida, Ichiro Tsuji, Takashi Yamakawa, Junko Furukawa, Kanako Ban, Koji Onuki, Yoshiaki Rai, Takako Morita, Yukio Koibuchi, Yoshio Kasahara
Publikováno v:
Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 25:51-56